Ketamine for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jan 2024: Trial registered, NCT06231563
  2. 1 Mar 2026: Trial started, NCT06231563

The trials

NCT06231563: Ketamine for Veterans With Parkinson's Disease

State
Under way
Phase
Phase 2
People
80 planned
Started
1 Mar 2026
Primary completion
30 Sep 2029
Arms
Ketamine
Results
None posted
  1. 30 Jan 2024: Trial registered
  2. 1 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as 0.2 mg/kg ketamine, 1st perfusion of ketamine, 2nd perfusion of ketamine, Anaket v, Calypsol, CLORKETAM 1000, IMALGENE 1000, Intranasal Ketamine (IN), Intranasal ketamine, Ketafol component ketamine, KETASOL 100, Ketamine Infusion, Narketan, Tekam, Ursotamin, Vetaket.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.